In Vivo Studies of [ <sup>161</sup> Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2–Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth Suppression
Sigrid Cold(University of Copenhagen), Lotte K. Kristensen, Trine B. Engel, Pragalath Sadasivam, Jesper Fonslet, Myrto Ischyropoulou(Max Planck Institute of Experimental Medicine), Carsten H. Nielsen(Pertamina (Indonesia)), Andreas Kjaer(University of Copenhagen), Mette M. Wessel
Cited by 0
Related Papers
CD4<sup>+</sup> and CD8a<sup>+</sup> PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models
|Theranostics|2019|105
High‐Load Gemcitabine Inorganic–Organic Hybrid Nanoparticles as an Image‐Guided Tumor‐Selective Drug‐Delivery System to Treat Pancreatic Cancer
|Advanced Materials|2023|35
Dicarbonyl <i>cis</i>-[M(CO)<sub>2</sub>(N,O)(C)(P)] (M = Re, <sup>99m</sup>Tc) Complexes with a New [2 + 1 + 1] Donor Atom Combination
|Inorganic Chemistry|2018|24
Quantitative PET Imaging of Tissue Factor Expression Using <sup>18</sup>F-Labeled Active Site–Inhibited Factor VII
|Journal of Nuclear Medicine|2015|19
Synthesis and evaluation of new mixed “2 + 1” Re, 99mTc and 186Re tricarbonyl dithiocarbamate complexes with different monodentate ligands
|Bioorganic & Medicinal Chemistry|2021|15